UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Fourth international consultation on incontinence recommendations of the international scientific committee: Evaluation and treatment of urinary incontinence, pelvic organ prolapse, and fecal incontinence

Neurourology and urodynamics, 2010-01, Vol.29 (1), p.213-240

2010

Volltextzugriff (PDF)

Combination treatment with mirabegron and solifenacin in patients with overactive bladder: exploratory responder analyses of efficacy and evaluation of patient-reported outcomes from a randomized, double-blind, factorial, dose-ranging, Phase II study (SYMPHONY)

World journal of urology, 2017-05, Vol.35 (5), p.827-838

2017

Volltextzugriff (PDF)

Trospium chloride has no effect on memory testing and is assay undetectable in the central nervous system of older patients with overactive bladder

International journal of clinical practice (Esher), 2010-08, Vol.64 (9), p.1294-1300

2010

Volltextzugriff (PDF)

EFFICACY OF VIBEGRON ON URGENCY URINARY INCONTINENCE AND PATIENT-REPORTED QUALITY OF LIFE: SUBGROUP ANALYSIS FROM THE EMPOWUR TRIAL

Continence (Amsterdam), 2023-09, Vol.7, p.100954, Article 100954

2023

Volltextzugriff (PDF)

Overactive bladder medication switch studies - Vive le différence?

International journal of clinical practice (Esher), 2008-11, Vol.62 (11), p.1639-1640

Staskin, D.

2008

Volltextzugriff (PDF)

Clinical safety, tolerability and efficacy of combination tolterodine/pilocarpine in patients with overactive bladder

International journal of clinical practice (Esher), 2014-08, Vol.68 (8), p.986-994

2014

Volltextzugriff (PDF)

Baseline incontinence severity is predictive of the percentage of patients continent after receiving once-daily trospium chloride extended release

International journal of clinical practice (Esher), 2009-06, Vol.63 (6), p.973-976

2009

Volltextzugriff (PDF)

Trospium chloride once-daily extended release is effective and well tolerated for the treatment of overactive bladder syndrome: an integrated analysis of two randomised, phase III trials

International journal of clinical practice (Esher), 2009-12, Vol.63 (12), p.1715-1723

2009

Volltextzugriff (PDF)

A practical guide to the evaluation and treatment of male lower urinary tract symptoms in the primary care setting

International journal of clinical practice (Esher), 2007-09, Vol.61 (9), p.1535-1546

2007

Volltextzugriff (PDF)

Prospective randomized controlled trial of extended-release oxybutynin chloride and tolterodine tartrate in the treatment of overactive bladder: results of the OBJECT Study

Mayo Clinic proceedings, 2001-04, Vol.76 (4), p.358-363

2001

Volltextzugriff (PDF)

A Reappraisal of Storage and Voiding Dysfunction

Current urology reports, 2012-12, Vol.13 (6), p.482-487

2012

Volltextzugriff (PDF)

The five 'Ps' of an incontinence clinical practice guideline

International journal of clinical practice (Esher), 2008-10, Vol.62 (10), p.1466-1467

Staskin, D. R.

2008

Volltextzugriff (PDF)

UP-03.204 A Flexible Dose Transdermal Oxybutynin Gel for the Treatment of Overactive Bladder: Phase III Results

Urology (Ridgewood, N.J.), 2011, Vol.78 (3), p.S412-S413

2011

Volltextzugriff (PDF)

In vivo comparison of suburethral sling materials

International Urogynecology Journal, 2006-02, Vol.17 (2), p.106-110

2006

Volltextzugriff (PDF)

STEP: Simplified Treatment of the Enlarged Prostate

International journal of clinical practice (Esher), 2010-03, Vol.64 (4), p.488-496

2010

Volltextzugriff (PDF)

Pelvic floor electrical stimulation in the treatment of genuine stress incontinence: A multicenter, placebo-controlled trial

American journal of obstetrics and gynecology, 1995-07, Vol.173 (1), p.72-79

1995

Volltextzugriff (PDF)

Effects of oxybutynin transdermal system on health-related quality of life and safety in men with overactive bladder and prostate conditions

International journal of clinical practice (Esher), 2008-01, Vol.62 (1), p.27-38

2008

Volltextzugriff (PDF)

297 LONG-TERM EFFICACY AND SAFETY OF VIBEGRON FOR OVERACTIVE BLADDER SYNDROME IN PATIENTS ≥65 YEARS OLD: ANALYSIS FROM THE EMPOWUR EXTENSION TRIAL

Continence (Amsterdam), 2022-06, Vol.2, p.100363, Article 100363

2022

Volltextzugriff (PDF)

297 LONG-TERM EFFICACY AND SAFETY OF VIBEGRON FOR OVERACTIVE BLADDER SYNDROME IN PATIENTS ≥65 YEARS OLD: ANALYSIS FROM THE EMPOWUR EXTENSION TRIAL

Continence (Amsterdam), 2022-06, Vol.2, p.1-2

2022

Volltextzugriff (PDF)

Urinary urgency - translating the evidence base into daily clinical practice

International journal of clinical practice, 2009-12, Vol.63 (12), p.1675-1682

2009

Volltextzugriff (PDF)

Patient‐reported outcomes from SYNERGY, a randomized, double‐blind, multicenter study evaluating combinations of mirabegron and solifenacin compared with monotherapy and placebo in OAB patients

Neurourology and urodynamics, 2018-01, Vol.37 (1), p.394-406

2018

Volltextzugriff (PDF)

Gore-Tex patch sling: 7 years later

Urology (Ridgewood, N.J.), 1999-10, Vol.54 (4), p.641-646

1999

Volltextzugriff (PDF)

Overactive bladder medication switch studies - Vive le différence?: Editorials

International journal of clinical practice (Esher), 2008-11, Vol.62 (11), p.1639-1640

Staskin, D.

2008

Volltextzugriff (PDF)

An Evaluation of the Efficacy and Safety of Vibegron in the Treatment of Overactive Bladder

Therapeutics and clinical risk management, 2022-01, Vol.18, p.171-182

2022

Volltextzugriff (PDF)

Transdermal delivery of drugs for urologic applications: Basic principles and applications

Urology (Ridgewood, N.J.), 2006-04, Vol.67 (4), p.657-664

2006

Volltextzugriff (PDF)

1 – 25 von 134

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(104)
Mit Volltextzugriff
(84)

Publikationsform

Sprache

Englisch
(133)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(88)
Life Sciences & Biomedicine
(77)
Science & Technology
(77)
Female
(68)
Urology & Nephrology
(47)
Male
(43)
Biological And Medical Sciences
(38)
Medical Sciences
(38)
Aged
(30)
Middle Aged
(30)
Adult
(25)
Nephrology. Urinary Tract Diseases
(25)
Urinary System Involvement In Other Diseases. Miscellaneous
(24)
Urinary Tract. Prostate Gland
(24)
Urology
(21)
General & Internal Medicine
(20)
Medicine, General & Internal
(20)
Urinary Incontinence
(20)
Treatment Outcome
(16)
Urinary Bladder, Overactive - Drug Therapy
(15)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Fourth international consultation on incontinence recommendations of the international scientific committee: Evaluation and treatment of urinary incontinence, pelvic organ prolapse, and fecal incontinence

Combination treatment with mirabegron and solifenacin in patients with overactive bladder: exploratory responder analyses of efficacy and evaluation of patient-reported outcomes from a randomized, double-blind, factorial, dose-ranging, Phase II study (SYMPHONY)

Trospium chloride has no effect on memory testing and is assay undetectable in the central nervous system of older patients with overactive bladder

EFFICACY OF VIBEGRON ON URGENCY URINARY INCONTINENCE AND PATIENT-REPORTED QUALITY OF LIFE: SUBGROUP ANALYSIS FROM THE EMPOWUR TRIAL

Overactive bladder medication switch studies - Vive le différence?

Clinical safety, tolerability and efficacy of combination tolterodine/pilocarpine in patients with overactive bladder

Baseline incontinence severity is predictive of the percentage of patients continent after receiving once-daily trospium chloride extended release

Trospium chloride once-daily extended release is effective and well tolerated for the treatment of overactive bladder syndrome: an integrated analysis of two randomised, phase III trials

A practical guide to the evaluation and treatment of male lower urinary tract symptoms in the primary care setting

Prospective randomized controlled trial of extended-release oxybutynin chloride and tolterodine tartrate in the treatment of overactive bladder: results of the OBJECT Study

A Reappraisal of Storage and Voiding Dysfunction

The five 'Ps' of an incontinence clinical practice guideline

UP-03.204 A Flexible Dose Transdermal Oxybutynin Gel for the Treatment of Overactive Bladder: Phase III Results

In vivo comparison of suburethral sling materials

STEP: Simplified Treatment of the Enlarged Prostate

Pelvic floor electrical stimulation in the treatment of genuine stress incontinence: A multicenter, placebo-controlled trial

Effects of oxybutynin transdermal system on health-related quality of life and safety in men with overactive bladder and prostate conditions

297 LONG-TERM EFFICACY AND SAFETY OF VIBEGRON FOR OVERACTIVE BLADDER SYNDROME IN PATIENTS ≥65 YEARS OLD: ANALYSIS FROM THE EMPOWUR EXTENSION TRIAL

297 LONG-TERM EFFICACY AND SAFETY OF VIBEGRON FOR OVERACTIVE BLADDER SYNDROME IN PATIENTS ≥65 YEARS OLD: ANALYSIS FROM THE EMPOWUR EXTENSION TRIAL

Urinary urgency - translating the evidence base into daily clinical practice

Patient‐reported outcomes from SYNERGY, a randomized, double‐blind, multicenter study evaluating combinations of mirabegron and solifenacin compared with monotherapy and placebo in OAB patients

Gore-Tex patch sling: 7 years later

Overactive bladder medication switch studies - Vive le différence?: Editorials

An Evaluation of the Efficacy and Safety of Vibegron in the Treatment of Overactive Bladder

Transdermal delivery of drugs for urologic applications: Basic principles and applications

Suchergebnisse filtern